Silk Road Medical Inc

Change company Symbol lookup

Select an option...

SILK Silk Road Medical Inc

XNIDX Nuveen Intermediate Duration Municipal Term Fund

PSBQ PSB Holdings Inc

RONI Rice Acquisition Corp II

SUP Superior Industries International Inc

NECB Northeast Community Bancorp Inc

NIDB Northeast Indiana Bancorp Inc

SPXC SPX Technologies Inc

ULTA Ulta Beauty Inc

HTGM HTG Molecular Diagnostics Inc

Go

Silk Road Medical, Inc. is a medical device company, which is focused on reducing the risk of stroke and its devastating impact. The Company has discovered an approach for the treatment of carotid artery disease called transcarotid artery revascularization, (TCAR), which relies on two concepts: minimally invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain and combines the endovascular techniques with fundamental surgical principles. Its product portfolio includes ENROUTE Transcarotid Neuroprotection System (NPS), ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014 Guidewire, and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. Its ENROUTE Transcarotid Stent System is placed during a period of temporary high-rate blood flow reversal, which is enabled by its ENROUTE Transcarotid NPS. It markets and sells products in the United States through a direct sales organization.